Key Highlights
- John Witkowski appointed as President & CEO of Solesis, effective immediately.
- Witkowski brings a wealth of experience from the medical device and biopharmaceutical industries.
- Strategic focus on driving long-term, sustainable growth and supporting customers.
Source: Business Wire
Notable Quotes
- “John brings nearly 30 years of experience across the medical device and biopharmaceutical industries. He is well positioned to lead Solesis in its next phase of growth.” – George Aitken-Davies, Chairman of the Board at Solesis
- “Joining a leader in the MedTech and Biopharma industries is exciting, especially when coupled with a period of growth like Solesis is currently experiencing.” – John Witkowski, President & CEO at Solesis
SoHC's Take
With the appointment of John Witkowski as the new President and CEO, Solesis underscores its commitment to excellence in serving the medical device and biopharmaceutical industries. Witkowski’s rich background, featuring significant leadership roles across key industry segments, positions him as the ideal leader to steer Solesis into its forthcoming growth phase. His proven track record in driving transformational growth, both organically and through mergers and acquisitions, is particularly noteworthy. This strategic move signals Solesis’s dedication to not only maintaining its leadership status in the market but also to fostering innovation and operational excellence in support of its customers. Witkowski’s vision for collaboration and his focus on supporting customers to benefit patients worldwide are in perfect alignment with Solesis’s mission. His leadership is expected to catalyze significant advancements in healthcare solutions, further enabling patients to lead healthier lives.
